These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 330747)

  • 41. Down-regulation of natural killer cell activity in MoLV leukemogenesis: evidence for tumor-cell-mediated suppression.
    Ofir R; Weinstein Y; Rager-Zisman B
    Nat Immun Cell Growth Regul; 1988; 7(2):77-86. PubMed ID: 2842667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on mouse Moloney virus induced tumours: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement dependent antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):513-23. PubMed ID: 50853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
    Bernstein ID; Wright PW; Cohen E
    J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune responses to weakly immunogenic virally induced tumors. II. Suppressive effects of the in vivo carried tumor YAC.
    Devens B; Galili N; Deutsch O; Naor D; Klein E
    Eur J Immunol; 1978 Aug; 8(8):573-8. PubMed ID: 699954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice.
    Risser R; Stockert E; Old LJ
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3918-22. PubMed ID: 211509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of alpha-fetoprotein on Moloney sarcoma virus oncogenesis: evidence for generation of antigen nonspecific suppressor T cells.
    Gershwin ME; Castles JJ; Ahmed A; Makishima R
    J Immunol; 1978 Dec; 121(6):2292-8. PubMed ID: 82580
    [No Abstract]   [Full Text] [Related]  

  • 48. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.
    Gillespie GY; Hansen CB; Hoskins RG; Russell SW
    J Immunol; 1977 Aug; 119(2):564-70. PubMed ID: 301897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors from lymphoid cell tumor affecting immune responses.
    Specter S; Schneider R; Friedman H
    Ann N Y Acad Sci; 1979; 332():531-8. PubMed ID: 394642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The immunodepressive effect of Friend virus III. Effects on spleen T cells.
    Dracott BN; Wedderburn N; Doenhoff MJ
    Immunology; 1977 Oct; 33(4):573-80. PubMed ID: 336523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum.
    Perry LL; Benacerraf B; McCluskey RT; Greene MI
    Am J Pathol; 1978 Aug; 92(2):491-506. PubMed ID: 307911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppression in vitro induced by leukemia virus-infected splenocytes (38544).
    Kamo I; Kateley JR; Kaplan G; Friedman H
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):383-6. PubMed ID: 1091933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased pathogenicity of murine leukemia virus-Moloney in gnotobiotic mice.
    Isaak DD; Bartizal KF; Caulfield MJ
    Leukemia; 1988 Aug; 2(8):540-4. PubMed ID: 3261822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenic and immunosuppressive components in soluble preparations from Moloney murine leukemia virus-induced tumor cells.
    Brandchaft PB; Aoki T; Silverman TN
    Int J Cancer; 1976 May; 17(5):678-85. PubMed ID: 57937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunologic cross-reactivity of antigen(s) induced by drug treatment in two leukemic sublines.
    Nicolin A; Bini A; Di Padova F; Goldin A
    J Immunol; 1976 May; 116(5):1347-9. PubMed ID: 58028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses.
    Taniyama T; Holden HT
    J Exp Med; 1979 Dec; 150(6):1367-82. PubMed ID: 229187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.
    Jennette JC; Feldman JD
    J Immunol; 1977 Jun; 118(6):2269-74. PubMed ID: 301157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunosuppression in mice after inoculation with 334C, a murine lymphatic leukemia-inducing virus.
    Schenk PJ; Buffett RF
    J Natl Cancer Inst; 1977 Mar; 58(3):665-71. PubMed ID: 190412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative immunological studies on cryosurgery and surgical operation using Moloney murine sarcoma virus-induced primary tumors in BALB/c mice.
    Kimura H
    Gan; 1978 Aug; 69(4):507-15. PubMed ID: 710802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.